Renfu Pharmaceutical (600079.SH): Ethyl eicosapentaenoate softgels obtained drug registration certificate

Zhitongcaijing · 09/02/2025 09:09

Zhitong Finance App News, Renfu Pharmaceutical (600079.SH) announced that Renfu Pharmaceutical (Wuhan) Co., Ltd. (“Wuhan Puck”), a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for ethyl eicosapentaenoate softgels approved and issued by the State Drug Administration. The approval of the ethyl eicosapentaenoate softgel indicates that the company is qualified to sell this drug in the domestic market. The product further enriches the company's product line, and its listing and sales will have a positive impact on the company.